Ge2p2 Global Foundation
Nonprofit profile at a glance
- EIN
- 812901344
- IRS 990-EZ coverage
- 2020–2025
- Forms available
- Form 990 2019, Form 990-EZ 2025, Form 990-N 2016
- Location
- Philadelphia, PA, USA
- Phone
- 2677144460
- Rating
- 88
- Verdict
- STRONG
- Rating confidence
- Moderate
- Sector
- Public, Society Benefit N.E.C.
Reported finances
- Revenue
- $40,025
- Expenses
- $61,451
- Assets
- $2,008
- Liabilities
- $32,042
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
6 people listed
Executive titles in this filing
- DAVID R CURRY MS (CEO, PRESIDENT, TREASURER)
People named in this filing
- JESTINA DOE ANDERSON PHD (DIRECTOR)
- ROBERT I FIELD PHD MPH JD (DIRECTOR)
- ROSS UPSHUR BA HONS MA MD MSC (DIRECTOR)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
The mission of ge2p2 global foundation (foundation) is to advance ethical and scientific rigor in research and evidence generation . . . Strengthening governance, policy and practice . . . Informing human rights action, humanitarian response, health, education, heritage stewardship, and sustainable development . . . Delivered by governments, international agencies, ingos, civil society organizations (csos), commercial entities, consortia and alliances, and individuals.
What it reported doing in 2025
The foundation operates through a portfolio of centers and programs to focus the work and engages the competencies, experience, and insights of a global network of elected "fellows" of the foundation. Fellows include academic, agency and government leaders, scientists, researchers, ethicists, field practitioners, domain and cultural context experts, scholars in the social and biosciences and the humanities, knowledge management experts, and many others. During 2025, the following centers were active: (1) center for vaccine ethics and policy (cvep), (2) center for informed consent integrity (cici), (3) center for disaster and humanitarian ethics (cdhe), (4) independent bioethics advisory committee (ibac), and (5) center for genomic medicine ethics and policy (cgmep).(1) cvep engages the full life-cycle of issues around global immunization and vaccines -- building and refining ethical frameworks; analyzing and communicating about vaccine evidence, ethics and policy; innovating new analytical, visualization and decision approaches and convening the vaccine community to consider evidence, ethics and practical solutions. Cvep also offers a knowledge-sharing service through publication of vaccines and global health: the week in review. This comprehensive weekly digest aggregates news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space.(2) cici addresses informed consent broadly and holds that "consent" grounded in open, evidence-based, accessible, understandable and materially-complete information is the bulwark of human rights, fundamental freedoms, and responsible governance. The center focuses on consent in research contexts across all the foundation's action sectors including health, human rights, humanitarian response, education and literacy, sustainable development, and heritage stewardship. This work includes producing knowledge sharing services and advisory services supporting development and implementation of responsible consent and assent practices. (3) cdhe focuses on ethics, evidence generation, and policy involving health interventions particularly immunization human rights, and overall humanitarian response to the full range of complex emergencies, fragile conflict-violence (fcv) contexts, and natural and manmade disasters.(4) ibac provides research, analysis and advisory analysis and recommendations on issues which may arise across the life cycle of clinical research and evidence generation based on its triad approach considering medical responsibility, operational soundness, and ethical resilience.(5) cgmep focuses on genomics, gene editing, and the wider ecology of convergent biosciences spanning ai- and data-enabled discovery, integrated multi-omics, synthetic and engineering biology, advanced cellular and tissue modelling including organoids, neurotechnologies, systems and predictive biosciences, and translational and precision health. The center examines governance, ethics and policy across this complex and rapidly evolving field.
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. Expenses are high relative to revenue and program spending has declined or grown slowly.
Rating breakdown
- Financial Efficiency: 94
- Transparency & Controls: 100
- Sustainability: 15
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 100%; rating input score 100
- Program expense ratio: 84.7%; rating input score 85
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
Sustainability
- Operating margin: -53.5%; rating input score 12; 12th percentile among comparable filings
- Total-asset coverage ratio: 0.03; rating input score 9; 9th percentile among comparable filings
- Liabilities to assets ratio: 15.96; rating input score 1; 1st percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: -18.2% per year; rating input score 0; 21st percentile among comparable filings
- Revenue growth: -26.8% per year; rating input score 0; 12th percentile among comparable filings
- Asset growth: -42.7% per year; rating input score 0; 5th percentile among comparable filings
Details
- Where the money goes: 100% of revenue deployed · 84.7% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $52K in reported program spending
- Leadership: top reported pay $0 · 6 people listed
- Consistency: 8 of 8 current checks pass
- Schedules: 3 filed schedules
- Filing history: 6 filing years from 2020 to 2025
- Contacts: How to reach this organization
- Money network: Resolved incoming and outgoing counterparties from filed money flows.
- Related organizations: 1 filed related-organization link
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Sustainability: Operating margin scored 12/100.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Sustainability: Total-asset coverage ratio scored 9/100.
- High — Growth: Asset growth scored 0/100.
- High — Sustainability: Liabilities to assets ratio scored 1/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.